Skip to main content
SpringerLink
Log in

Current Male Contraceptives and Experimental Nonhormonal Contraceptive Research

  • Chapter
  • First Online:
Female and Male Contraception

Part of the book series: Trends in Andrology and Sexual Medicine ((TASM))

  • 1269 Accesses

Abstract

Some women are unable to use currently available female contraceptives due to health conditions or side effects, leaving some couples without effective contraceptive options. In addition, many men wish to take active responsibility for family planning. Thus, there is a great need for male contraceptives to prevent unintended pregnancy, of which 80–90 million occur annually. At present, effective male contraceptive options are condoms and vasectomy, which are not ideal for all men. Therefore, efforts are under way to develop novel male contraceptives. This paper will briefly review the advantages and disadvantages of condoms and vasectomies and then discuss the research directed toward the development of novel methods of male contraception.

For Meriggiola and Gemzell-“Female and Male Contraception” Published by Springer.

Disclosure Statement: The author has received research funding from Clarus Therapeutics.

Capsule: This chapter reviews the two current, effective forms of male contraception, condoms and vasectomy, as well as efforts to develop new nonhormonal male contraceptives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Heller CG, Clermont Y. Kinetics of the germinal epithelium in man. Recent Prog Horm Res. 1964;20:545–71.

    CAS  PubMed  Google Scholar 

  2. DeKretser DM. Morphology and physiology of the testis. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 2nd ed. Philadelphia: Lippincott; 1995. p. 1032–41.

    Google Scholar 

  3. Silber SJ, Ord T, Balmaceda J, Patrizio P, Asch RH. Congenital absence of the vas deferens. The fertilizing capacity of human epididymal sperm. N Engl J Med. 1990;323:1788–92.

    Article  CAS  PubMed  Google Scholar 

  4. Matsumoto AM. Testosterone administration in older men. Endocrinol Metab Clin N Am. 2013;42:271–86.

    Article  CAS  Google Scholar 

  5. Roth MY, Page ST, Lin K, et al. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. J Clin Endocrinol Metab. 2010;95:3806–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Haws JM, Morgan GT, Pollack AE, et al. Clinical aspects of vasectomies performed in the United States in 1995. Urology. 1995;52:685–91.

    Article  Google Scholar 

  7. Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: US, 2011–2013. Natl Health Stat Rep. 2015;86:1–14.

    Google Scholar 

  8. Philp T, Guillebaud J, Budd D. Complications of vasectomy: review of 16,000 patients. Br J Urol. 1984;56:745–8.

    Article  CAS  PubMed  Google Scholar 

  9. Li S-Q, Goltein M, Shu J, Huber D. The no-scalpel vasectomy. J Urol. 1991;145:341–4.

    Article  CAS  PubMed  Google Scholar 

  10. Nirapathpongporn A, Huber DJ, Krieger JN. No scalpel vasectomy at the King's birthday vasectomy festival. Lancet. 1990;335:894–5.

    Article  CAS  PubMed  Google Scholar 

  11. Skriver M, Skovsgaard F, Miskowiak J. Conventional or Li vasectomy: a questionnaire study. Br J Urol. 1997;79:596–8.

    Article  CAS  PubMed  Google Scholar 

  12. McMahon AJ, Buckley J, Taylor A, et al. Chronic testicular pain following vasectomy. Br J Urol. 1992;69:188–91.

    Article  CAS  PubMed  Google Scholar 

  13. Myers SA, Mershon CE, Fuchs EF. Vasectomy reversal for treatment of the post-vasectomy pain syndrome. J Urol. 1997;157:518–20.

    Article  CAS  PubMed  Google Scholar 

  14. Jequier AM. Vasectomy related infertility: a major and costly medical problem. Hum Reprod. 1998;13:1757–9.

    Article  CAS  PubMed  Google Scholar 

  15. Belker AM, Thomas AJ, Fuchs EF, et al. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol. 1991;145:505–11.

    Article  CAS  PubMed  Google Scholar 

  16. Heidenreich A, Bonfig R, Wilbert DM, et al. Risk factors for anti-sperm antibodies in infertile men. Am J Reprod Immunol. 1994;31:69–76.

    Article  CAS  PubMed  Google Scholar 

  17. Peterson HB, Howards SS. Vasectomy and prostate cancer: the evidence to date. Fertil Steril. 1998;70:201–3.

    CAS  PubMed  Google Scholar 

  18. Manson JE, Ridker PM, Spelsberg A, et al. Vasectomy and subsequent cardiovascular disease in US physicians. Contraception. 1999;59:181–6.

    Article  CAS  PubMed  Google Scholar 

  19. DʼAnna LH, Korosteleva O, Warner L, et al. Factors associated with condom use problems during vaginal sex with main and non-main partners. Sex Transm Dis. 2012;39:687–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plan Perspect. 1999;31:64–72.

    Article  CAS  Google Scholar 

  21. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure from the 2006–2010 national survey of family growth. Perspec Sex Repro Health. 2017;49:7–16.

    Article  Google Scholar 

  22. Fennell J. “And isn’t that the point?” pleasure and contraceptive decisions. Contraception. 2014;89:264–70.

    Article  PubMed  Google Scholar 

  23. Levy DA, Khouader S, Leynadier F. Allergy to latex condoms. Allergy. 1998;53:110–2.

    Article  Google Scholar 

  24. Steiner MJ, Dominik R, Rountree RW, et al. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial. Obstet Gynecol. 2003;101:539–47.

    CAS  PubMed  Google Scholar 

  25. Walsh TL, Frezieres RG, Peacock K, et al. Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial. Perspect Sex Repro Health. 2003;35:79–86.

    Google Scholar 

  26. Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev. 2006;1:CD003550.

    Google Scholar 

  27. Nya-Ngatchou JJ, Amory JK. New approaches to male non-hormonal contraception. Contraception. 2013;87:296–9.

    Article  CAS  PubMed  Google Scholar 

  28. No a l. Gossypol-a new antifertility agent for males. Gynecol Obstet Investig. 1979;10:163–76.

    Article  Google Scholar 

  29. Liu GZ, Lyle KC, Cao J. Clinical trial of gossypol as a male contraceptive drug Part I: Efficacy study. Fertil Steril. 1987;48:459–61.

    Article  CAS  PubMed  Google Scholar 

  30. Liu GZ, Lyle KC, Cao J. Clinical trial of gossypol as a male contraceptive drug Part II: Hypokalemia study. Fertil Steril. 1987;48:462–5.

    Article  CAS  PubMed  Google Scholar 

  31. Waites GM, Wang C, Griffin PK. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl. 1998;21:8–12.

    Article  CAS  PubMed  Google Scholar 

  32. Coutinho EM. Gossypol: a contraceptive for men. Contraception. 2002;65:259–63.

    Article  CAS  PubMed  Google Scholar 

  33. Qian SZ. Tripterygium wilfordii, a Chinese herb effective in male fertility regulation. Contraception. 1987;36:335–45.

    Article  CAS  PubMed  Google Scholar 

  34. Huynh PN, Hikim AP, Wang C, et al. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rates. J Androl. 2000;21:689–99.

    CAS  PubMed  Google Scholar 

  35. Cheng CY, Silvestrini B, Griima J, et al. Two new male contraceptive exert their effects by depleting germ cells prematurely from the testis. Biol Reprod. 2001;65:449–61.

    Article  CAS  PubMed  Google Scholar 

  36. Mruk DD, Cheng CY. Testin and actin are key molecular targets of adjudin, an anti-spermatogenic agent, in the testes. Spermatogenesis. 2011;1:137–46.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mok K-W, Mruk DD, Lie PPY, et al. Adjudin, a potential male contraceptive, exerts its effects locally in the seminiferous epithelium of mammalian testes. Reproduction. 2011;141:571–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Mruk DD, Wong CH, Silvestrini B, Cheng CY. A male contraceptive targeting germ cell adhesion. Nat Med. 2006;12:1323–8.

    Article  CAS  PubMed  Google Scholar 

  39. Chen H, Mruk DD, Xia W, et al. Effective delivery of male contraceptives behind the blood-testis barrier- lessons from Adjudin. Curr Med Chem. 2016;23:701–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Tash JS, Attardi B, Hild SA, et al. A novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose. Biol Reprod. 2008;78:1127–38.

    Article  CAS  PubMed  Google Scholar 

  41. Tash JS, Chakrasali R, Jakkaraj SR, et al. Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 and EEF1A1, and stimulates II1a transcription in rat Sertoli cells. Biol Reprod. 2011;78:1139–52.

    Article  CAS  Google Scholar 

  42. O'Rand MG, Widgren EE, Hamil KG, et al. Functional studies of EPPIN. Biochem Soc Trans. 2011;39:1447–9.

    Article  CAS  PubMed  Google Scholar 

  43. O’Rand MG, Widgren EE, Sivashanmugam P, et al. Reversible immunocontraception in male monkeys immunized with EPPIN. Science. 2004;306:1189–90.

    Article  PubMed  CAS  Google Scholar 

  44. O'Rand MG, Silva EJ, Hamil KG. Non-hormonal male contraception: a review and development of an EPPIN based contraceptive. Pharmacol Ther. 2016;157:105–11.

    Article  CAS  PubMed  Google Scholar 

  45. O'Rand MG, Hamil KG, Adevai T, Zelinski M. Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive. PLoS One. 2018;19:e0195953.

    Article  CAS  Google Scholar 

  46. Li L, Sha Y, Wang X, et al. Whole-exome sequencing identified a homozygous BRDT mutation in a patient with acephalic spermatozoa. Oncotarget. 2017;8:19914–22.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Matzuk MM, McKeown MR, Filippakopoulos P, et al. Small-molecule inhibition of BRDT for male contraception. Cell. 2012;150:673–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Zdrojewicz Z, Konieczny R, Papier P, Szten F. Brdt Bromodomains inhibitors and other modern means of male contraception. Adv Clin Exp Med. 2015;24:705–14.

    Article  PubMed  Google Scholar 

  49. Wolbach SB, Howe PR. Tissue changes following deprivation of fat soluble A Vitamin. J Exp Med. 1925;42:753–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Vernet N, Dennefeld C, Rochett-Egly C, et al. Retinoic acid metabolism and signaling pathways in the adult and developing mouse testis. Endocrinology. 2006;147:96–110.

    Article  CAS  PubMed  Google Scholar 

  51. Koubova J, Menke D, Zhou Q, et al. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci U S A. 2006;103:2472–9.

    Article  CAS  Google Scholar 

  52. Dufour JM, Kim KH. Cellular and subcellular localization of six retinoid receptors in rat testis during postnatal development: identification of potential heterodimeric receptors. Biol Reprod. 1999;61:1300–8.

    Article  CAS  PubMed  Google Scholar 

  53. Lufkin T, Lohnes D, Mark M, et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci U S A. 1993;90:7225–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Lohnes D, Kastner P, Dierich A, et al. Function of retinoic acid receptor gamma in the mouse. Cell. 1993;73:643–58.

    Article  CAS  PubMed  Google Scholar 

  55. Kastner P, Mark M, Leid M, et al. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev. 1996;10:80–92.

    Article  CAS  PubMed  Google Scholar 

  56. Schulze GE, Clay RJ, Mezza LE, et al. BMS-189453, a novel retinoid receptor antagonist, is a potent testicular toxin. Toxicol Sci. 2001;59:297–308.

    Article  CAS  PubMed  Google Scholar 

  57. Chung SS, Wang X, Roberts SS, et al. Oral administration of a retinoic acid receptor antagonist reversibly inhibits spermatogenesis in mice. Endocrinology. 2011;152:2492–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Chung SS, Wang X, Wolgemuth DJ. Prolonged oral administration of a pan-retinoic acid receptor antagonist inhibits spermatogenesis in mice with a rapid recovery and changes in the expression of influx and efflux transporters. Endocrinology. 2016;157:1601–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Chung SS, Cuellar RA, Wang X, et al. Pharmacological activity of retinoic acid receptor alpha-selective antagonists in vitro and in vivo. ACS Med Chem Lett. 2013;4:446–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Heller CG, Moore DJ, Paulsen CA. Suppression of spermatogenesis and chronic toxicity in men by a new series of bis(dichloroacetyl)diamines. Toxicol Appl Pharmacol. 1961;3:1–11.

    Article  CAS  PubMed  Google Scholar 

  61. Coulston F, Beyler AL, Drobeck HP. The biologic actions of a new series of bis(dichloroacetyl)diamines. Toxicol Appl Pharmacol. 1960;2:715–21.

    Article  CAS  PubMed  Google Scholar 

  62. Beyler AL, Potts GO, Coulston F, Surrey AR. The selective testicular effects of certain bis(dichloroacetyl)diamines. Endocrinology. 1961;69:819–33.

    Article  CAS  Google Scholar 

  63. Amory JK, Muller CH, Shimshoni AJ, et al. Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis. J Androl. 2011;32:111–9.

    Article  CAS  PubMed  Google Scholar 

  64. Paik J, Haenisch M, Muller CH, et al. Inhibition of retinoic acid biosynthesis by the bisdichloroacetyldiamine WIN 18,446 markedly suppresses spermatogenesis and alters retinoid metabolism in mice. J Biol Chem. 2014;289:15104–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Chen Y, Zhu J, Ho Hong K, et al. Structural basis of ALDH1A2 inhibition by irreversible and reversible small molecule inhibitors. ACS Chem Biol. 2018;13:582–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Ren DJ, Navarro B, Perez G, et al. A sperm ion channel required for sperm motility and male fertility. Nature. 2001;413:603–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Qi H, Moran MM, Navarro B, et al. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility. Proc Natl Acad Sci U S A. 2017;104:1219–23.

    Article  CAS  Google Scholar 

  68. Carlson AE, Burnett LA, del Camino D, et al. Pharmacological targeting of native CatSper channels reveals a required role in maintenance of sperm hyperactivation. PLoS One. 2009;4:e6844.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Widyowati R, Agil M. Chemical constituents and bioactivities of several Indonesian plants typically used in jamu. Chem Pharmaceut Bull. 2018;66:506–18.

    Article  CAS  Google Scholar 

  70. Guha SK, Singh G, Anand S, et al. Phase I clinical trial of an injectable contraceptive for the male. Contraception. 1993;48:367–75.

    Article  CAS  PubMed  Google Scholar 

  71. Guha SK, Singh G, Ansari S, et al. Phase II clinical trial of a vas deferens injectable contraceptive for the male. Contraception. 1997;56:245–50.

    Article  CAS  PubMed  Google Scholar 

  72. Lohiya NK, Alam I, Hussain M, et al. RISUG: an intravasal injectable male contraceptive. Indian J Med Res. 2014;140:S63–72.

    PubMed  PubMed Central  Google Scholar 

  73. Waller D, Bolick D, Lissner E, et al. Azoospermia in rabbits following an intravas injection of Vasalgel™. Basic Clin Androl. 2016;26:6.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Colagross-Schouten A, Lemoy MJ, Keesler RI, et al. The contraceptive efficacy of intravas injection of Vasalgel™ for adult male rhesus monkeys. Basic Clin Androl. 2017;27:4.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Waller D, Bolick D, Lissner E, et al. Reversibility of Vasalgel™ male contraceptive in a rabbit model. Basic Clin Androl. 2016;26:6.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Zhao SC, Zhang SP, Yu RC. Intravasal injection of formed-in-place silicone rubber as a method of vas occlusion. Int J Androl. 1992;15:460–4.

    Article  CAS  PubMed  Google Scholar 

  77. Zhao SC, Lian YH, Yu RC, Zhang SP. Recovery of fertility after removal of polyurethane plugs from the human vas deferens occluded for up to 5 years. Int J Androl. 1992;15:465–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington, Seattle, WA, USA

    John K. Amory

Authors
  1. John K. Amory
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John K. Amory .

Editor information

Editors and Affiliations

  1. Department of Medical and Surgical Science, University of Bologna, Clinic of Gynecology and Physiopathology of Reproduction, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

    Maria Cristina Meriggiola

  2. Department of Women’s and Children’s Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

    Kristina Gemzell-Danielsson

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Amory, J.K. (2021). Current Male Contraceptives and Experimental Nonhormonal Contraceptive Research. In: Meriggiola, M.C., Gemzell-Danielsson, K. (eds) Female and Male Contraception. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-70932-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70932-7_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70931-0

  • Online ISBN: 978-3-030-70932-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation